OpenRegistry
Companies House/Oxford/Company profile

OXFORD DRUG DESIGN LIMITED

Active
04305857·incorporated 2001-10-17

OXFORD DRUG DESIGN LIMITED is an active UK private limited company, incorporated on 17 October 2001 at Companies House (number 04305857; OpenRegistry canonical ID GB-04305857-oxford-drug-design-limited). Sophymarine's OpenRegistry classifies it under SIC 72110 (Research and experimental development on biotechnology), one of 4,267 active UK entities in that code and one of 11,665 active companies registered in Oxford (postcode OX1). Programmatic access via MCP at https://openregistry.sophymarine.com/mcp.

Status
Active
Type
Private Limited Company
Incorporated
2001-10-17
Registered Address
OXFORD CENTRE FOR INNOVATION BLUE BOAR COURT, 9 ALFRED STREET, OXFORD, OX1 4EH, ENGLAND
SIC
72110 — Research and experimental development on biotechnology
Country of origin
United Kingdom

Accounts

Last filed accounts made up to 2024-12-31. Next accounts due 2026-09-30. Financial year-end: 31/12. Filing class: TOTAL EXEMPTION FULL.

Confirmation statement

Last confirmation statement made up to 2025-10-29. Next confirmation statement due 2026-11-12.

Persons with significant control

  • No individual or entity with significant control has been identified.

3 historical PSC records have ceased:

  • Ip Venture Fund (Gp) Limited (England reg. 05852196). Notified 2016-04-06. Ceased 2019-07-29.
    • Has significant influence or control
  • Mr Michael Underwood born 1943 resident in England, British national. Notified 2016-04-06. Ceased 2019-05-20.
    • Owns 25–50% of shares
    • Holds 25–50% of voting rights
  • Ip2ipo Limited (England reg. 04072979). Notified 2016-04-06. Ceased 2019-07-29.
    • Has significant influence or control

Previous names

OXFORD DRUG DESIGN LIMITED has previously traded as:

  • INHIBOX LIMITED (until 2017-05-15)

Similar UK companies

Other companies registered under SIC 72110 (Research and experimental development on biotechnology):

Other companies registered in Oxford: